More on LH
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $325.07 |
|
|||
| Open | $326.05 | ||||
| 52 Wk High | $141.32 | ||||
| 52 Wk Low | $97.79 | ||||
| Day High | $327.50 | ||||
| Day Low | $316.12 | ||||
| P/E | 50.87 | ||||
| EPS | $6.25 | ||||
| Volume | 706,252 | ||||
- Opko Health stock soars on $722M BioReference asset sale
- Labcorp to buy BioReference Health assets from OPKO for $722M
- Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
- Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test
- Form 8-K LABCORP HOLDINGS INC. For: Sep 30
- Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
- Form 8-K LABCORP HOLDINGS INC. For: Sep 22
- Mizuho comments on DGX and LH post CMS on Monday
- Laboratory Corporation of America (LH) PT Raised to $361 at Baird
- Evercore comments on LH and DGX post CMS on Monday
Entities mentioned with LH
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Dividend | View Related Stories »
- Show More...
